Filing Flows › Comparisons › IBIO vs YARW
iBio vs Yarrow Bioscience: IBIO and YARW compared
iBio is the larger company: $100K of revenue in its latest quarter (Q1 FY26) against $97K for Yarrow Bioscience (Q2 2026).
Where the money goes: IBIO and YARW
iBio (IBIO) · Q1 FY26
iBio, Q1 FY26: revenue $100K, net loss $5.7M, operating cash flow −$5.7M. The chart follows the revenue to costs, profit and cash.
Yarrow Bioscience (YARW) · Q2 2026
Yarrow Bioscience, Q2 2026: revenue $97K (+41% year over year), net loss $3.0M, operating cash flow −$2.0M. The chart follows the revenue to costs, profit and cash.
| iBio (IBIO) | Yarrow Bioscience (YARW) | |
|---|---|---|
| Latest quarter | Q1 FY26 | Q2 2026 |
| Revenue | $100K | $97K |
| Revenue growth, Y/Y | — | +41% |
| Operating margin | n/m | n/m |
| Net earnings | −$5.7M | −$3.0M |
| Operating cash flow | −$5.7M | −$2.0M |
Questions
Which is bigger, iBio or Yarrow Bioscience?
iBio is the larger company: $100K of revenue in its latest quarter (Q1 FY26) against $97K for Yarrow Bioscience (Q2 2026).
More: iBio earnings · how iBio makes money · Yarrow Bioscience earnings · how Yarrow Bioscience makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 12, 2025; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.